Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Supportive care have to be built-in earlier to fulfill the distinctive emotional, sensible and fertility-related wants of youthful girls going through a most...
The FDA authorized Nubeqa for metastatic castration-sensitive prostate most cancers primarily based on considerably improved radiographic progression-free survival information.America Meals and Drug Administration...
Imdelltra improved survival and high quality of life versus chemotherapy as second-line remedy for small cell lung most cancers, reinforcing it as a...
